Skip to main content

Articles

Page 4 of 60

  1. Elevated glycated hemoglobin (HbA1c) is associated with a higher burden of subclinical atherosclerosis (SA). However, the association with SA of earlier insulin resistance markers is poorly understood. The stu...

    Authors: Josep Iglesies-Grau, Ana Garcia-Alvarez, Belén Oliva, Guiomar Mendieta, Inés García-Lunar, José J. Fuster, Ana Devesa, Cristina Pérez-Herreras, Antonio Fernández-Ortiz, Ramon Brugada, Borja Ibanez, Rodrigo Fernandez-Jimenez and Valentin Fuster
    Citation: Cardiovascular Diabetology 2023 22:350
    Content type: Research Published on:

  2. Previous studies have found that the triglyceride glucose index (TyG index) trajectories are associated with cardiovascular diseases. However, the association between the patterns of TyG index trajectories and...

    Authors: Fengling Xin, Shuyou He, Yu Zhou, Xueni Jia, Yulong Zhao and Hui Zhao
    Citation: Cardiovascular Diabetology 2023 22:347
    Content type: Research Published on:

  3. This study aimed to evaluate the association of triglyceride-glucose (TyG) index, an insulin resistance surrogate biomarker, with first stroke in a hypertensive population and to explore potential influencing ...

    Authors: Nan Zhang, Xiying Chi, Ziyi Zhou, Yun Song, Shuqun Li, Jiafeng Xu and Jianping Li
    Citation: Cardiovascular Diabetology 2023 22:346
    Content type: Research Published on:

  4. The association between obesity indicators and mortality in individuals with diabetes remains unclear, and data on cardiovascular mortality are scarce. Therefore, we investigated the associations between the f...

    Authors: Chung-Yen Lu, Hsiao-Hui Chen, Kuan-Hui Chi and Pei-Chun Chen
    Citation: Cardiovascular Diabetology 2023 22:345
    Content type: Research Published on:

  5. In the last years, the classical pattern of diabetic kidney disease (DKD) has been partially overcome, because of the uncovering of a new DKD phenotype with significant renal dysfunction without presence of al...

    Authors: Maurizio Di Marco, Sabrina Scilletta, Nicoletta Miano, Nicola Marrano, Annalisa Natalicchio, Francesco Giorgino, Stefania Di Mauro, Agnese Filippello, Alessandra Scamporrino, Paola Tribulato, Giosiana Bosco, Francesco Di Giacomo Barbagallo, Roberto Scicali, Agostino Milluzzo, Teresa Ballirò, Lucia Frittitta…
    Citation: Cardiovascular Diabetology 2023 22:344
    Content type: Research Published on:

  6. Prior studies suggest a link between metabolic dysfunction-associated steatotic liver disease (MASLD) and incident arrhythmias, including atrial fibrillation (AF). However, robust data are lacking from cohorts...

    Authors: Tracey G. Simon, Fahim Ebrahimi, Bjorn Roelstraete, Hannes Hagström, Johan Sundström and Jonas F. Ludvigsson
    Citation: Cardiovascular Diabetology 2023 22:343
    Content type: Research Published on:

  7. Data are limited on the association of metabolic dysfunction-associated fatty liver disease (MAFLD) with systemic atherosclerosis. This study aimed to examine the relationship between MAFLD and the extent of a...

    Authors: Yanli Zhang, Zhang Xia, Xueli Cai, Xin Su, Aoming Jin, Lerong Mei, Jing Jing, Suying Wang, Xia Meng, Shan Li, Mengxing Wang, Tiemin Wei, Yongjun Wang, Yan He and Yuesong Pan
    Citation: Cardiovascular Diabetology 2023 22:342
    Content type: Research Published on:

  8. Previous studies using trajectory models focused on examining the longitudinal changes in triglyceride-glucose (TyG) levels and lifestyle scores separately, without exploring the joint evolution of these two f...

    Authors: Hui Zhou, Xiong Ding, Yulong Lan, Shuohua Chen, Shouling Wu and Dan Wu
    Citation: Cardiovascular Diabetology 2023 22:341
    Content type: Research Published on:

  9. Olive oil consumption has been inversely associated with the risk of type 2 diabetes (T2D) and cardiovascular disease (CVD). However, the impact of olive oil consumption on plasma metabolites remains poorly un...

    Authors: Jesús F. García-Gavilán, Nancy Babio, Estefanía Toledo, Zhila Semnani-Azad, Cristina Razquin, Courtney Dennis, Amy Deik, Dolores Corella, Ramón Estruch, Emilio Ros, Montserrat Fitó, Fernando Arós, Miquel Fiol, José Lapetra, Rosa Lamuela-Raventos, Clary Clish…
    Citation: Cardiovascular Diabetology 2023 22:340
    Content type: Research Published on:

  10. The risk of cardiovascular disease (CVD) depended on the magnitude and exposure duration of insulin resistance (IR). This study aimed to investigate the associations of cumulative metabolic score for IR (cumME...

    Authors: Xue Tian, Shuohua Chen, Qin Xu, Xue Xia, Yijun Zhang, Penglian Wang, Shouling Wu and Anxin Wang
    Citation: Cardiovascular Diabetology 2023 22:339
    Content type: Research Published on:

  11. Previous observational studies have documented an inverse association of birthweight with myocardial infarction (MI) but a positive association with atrial fibrillation (AF). However, the causality of these as...

    Authors: Lijie Kong, Yiying Wang, Chaojie Ye, Chun Dou, Dong Liu, Min Xu, Jie Zheng, Ruizhi Zheng, Yu Xu, Mian Li, Zhiyun Zhao, Jieli Lu, Yuhong Chen, Weiqing Wang, Ruixin Liu, Yufang Bi…
    Citation: Cardiovascular Diabetology 2023 22:338
    Content type: Research Published on:

  12. Subjects with type 2 diabetes (T2D) have a higher risk of in-stent restenosis and stent thrombosis. The activation of the glucagon-like peptide-1 receptor (GLP-1R) has been suggested to induce several effects ...

    Authors: Irene Santos-Pardo, Nils Witt, Oskar Angerås and Thomas Nyström
    Citation: Cardiovascular Diabetology 2023 22:337
    Content type: Research Published on:

  13. The effects of diabetes on the cardiac and aortic structure and function remain unclear. Detecting and intervening these variations early is crucial for the prevention and management of complications. Cardiova...

    Authors: Zhaoyue Li, Jie Xiong, Yutong Guo, Hao Tang, Bingchen Guo, Bo Wang, Dianyu Gao, Zengxiang Dong and Yingfeng Tu
    Citation: Cardiovascular Diabetology 2023 22:336
    Content type: Research Published on:

  14. The assessment of obesity-related health risks has traditionally relied on the Body Mass Index and waist circumference, but their limitations have propelled the need for a more comprehensive approach. The diff...

    Authors: Marta Lopez-Yus, Carmen Casamayor, Juan Jose Soriano-Godes, Sofia Borlan, Yolanda Gonzalez-Irazabal, Maria Pilar Garcia-Sobreviela, Beatriz Garcia-Rodriguez, Raquel del Moral-Bergos, Pilar Calmarza, Jose Maria Artigas, Silvia Lorente-Cebrian, Vanesa Bernal-Monterde, Alejandro Sanz-Paris and Jose M. Arbones-Mainar
    Citation: Cardiovascular Diabetology 2023 22:335
    Content type: Research Published on:

  15. Stress hyperglycemia ratio (SHR), associated with adverse outcomes in patients with ST-segment elevation myocardial infarction (STEMI), has several definitions. This study aims to assess the prognostic value o...

    Authors: Wang Liao, Yuwen Chen, Qiyue Gao, Rongrong Gan, Ming Li, Zhenliang Liu, Jiasheng Liang, Henghua Cui, Kaida Ren, Yabin Liu, Zhengdong Wang, Jun Jiang and Qucheng Wei
    Citation: Cardiovascular Diabetology 2023 22:334
    Content type: Research Published on:

  16. Insulin resistance is a pivotal risk factor for cardiovascular diseases, and the triglyceride-glucose (TyG) index is a well-established surrogate of insulin resistance. This study aimed to investigate the prog...

    Authors: Yu Zhang, Ce Zhang, Lin Jiang, Lianjun Xu, Jian Tian, Xueyan Zhao, Dong Wang, Yin Zhang, Kai Sun, Channa Zhang, Bo Xu, Wei Zhao, Rutai Hui, Runlin Gao, Jizheng Wang, Xinxing Feng…
    Citation: Cardiovascular Diabetology 2023 22:333
    Content type: Research Published on:

  17. Concurrent insulin resistance and elevated blood pressure are commonly observed in cardiovascular disease (CVD) and have long been proposed to contribute to CVD. However, the temporal relationship between them...

    Authors: Kuangyi Wu, Huancong Zheng, Weiqiang Wu, Guanzhi Chen, Zefeng Cai, Zhiwei Cai, Yulong Lan, Dan Wu, Shouling Wu and Youren Chen
    Citation: Cardiovascular Diabetology 2023 22:332
    Content type: Research Published on:

  18. Endothelial–mesenchymal transition (EndMT) plays a crucial role in promoting myocardial fibrosis and exacerbating cardiac dysfunction. Dapagliflozin (DAPA) is a sodium–glucose-linked transporter 2 (SGLT-2) inh...

    Authors: Weijie Wang, Yilan Li, Yanxiu Zhang, Tao Ye, Kui Wang, Shuijie Li and Yao Zhang
    Citation: Cardiovascular Diabetology 2023 22:331
    Content type: Research Published on:

  19. This post-hoc analysis of the DELIGHT trial assessed effects of the SGLT2 inhibitor dapagliflozin on iron metabolism and markers of inflammation.

    Authors: Akihiko Koshino, Brendon L. Neuen, Niels Jongs, Carol Pollock, Peter J. Greasley, Eva-Marie Andersson, Ann Hammarstedt, Cecilia Karlsson, Anna Maria Langkilde, Takashi Wada and Hiddo J.L. Heerspink
    Citation: Cardiovascular Diabetology 2023 22:330
    Content type: Research Published on:

  20. Authors: Kamel Mohammedi, Audrey Cordon, Vincent Rigalleau, Ninon Foussard, Céline Bairras-Martin, Thierry Couffinhal, Julien Bezin and Antoine Benard
    Citation: Cardiovascular Diabetology 2023 22:329
    Content type: Matters Arising Published on:

  21. In the Netherlands, more than one million patients have type 2 diabetes (T2D), and approximately 36% of these patients have chronic kidney disease (CKD). Yearly medical costs related to T2D and CKD account for...

    Authors: Sara W. Quist, Alexander V. van Schoonhoven, Stephan J. L. Bakker, Michał Pochopień, Maarten J. Postma, Jeanni M. T. van Loon and Jeroen H. J. Paulissen
    Citation: Cardiovascular Diabetology 2023 22:328
    Content type: Research Published on:

  22. Matrix metalloproteinase 12 (MMP12) is a macrophage-secreted protein that is massively upregulated as a pro-inflammatory factor in metabolic and vascular tissues of mice and humans suffering from cardiometabol...

    Authors: Melina Amor, Valentina Bianco, Martin Buerger, Margarete Lechleitner, Nemanja Vujić, Anja Dobrijević, Alena Akhmetshina, Anita Pirchheim, Birgit Schwarz, Ariane R. Pessentheiner, Franziska Baumgartner, Katharina Rampitsch, Silvia Schauer, Iva Klobučar, Vesna Degoricija, Gudrun Pregartner…
    Citation: Cardiovascular Diabetology 2023 22:327
    Content type: Research Published on:

  23. Advanced glycation end products (AGEs) have been linked to cardiovascular disease (CVD), especially coronary heart disease (CHD), but their role in CVD pathogenesis remains unclear. Therefore, we investigated ...

    Authors: Jinluan Chen, Banafsheh Arshi, Komal Waqas, Tianqi Lu, Daniel Bos, M. Arfan Ikram, André G. Uitterlinden, Maryam Kavousi and M. Carola Zillikens
    Citation: Cardiovascular Diabetology 2023 22:326
    Content type: Research Published on:

  24. The triglyceride-glucose (TyG) index is a predictor of cardiovascular diseases; however, to what extent the TyG index is associated with cardiovascular diseases through renal function is unclear. This study ai...

    Authors: Cancan Cui, Lin Liu, Te zhang, Ling Fang, Zhanhao Mo, Yitian Qi, Jia Zheng, Zhijia Wang, Haikun Xu, Han Yan, Siqi Yue, Xuekui Wang and Zhiyuan Wu
    Citation: Cardiovascular Diabetology 2023 22:325
    Content type: Research Published on:

  25. Bempedoic Acid (BA) is a novel Lipid-Lowering Therapy (LLT). We performed a systematic review and meta-analysis to assess the efficacy and safety of BA in patients with hypercholesterolemia.

    Authors: Ovidio De Filippo, Fabrizio D’Ascenzo, Mario Iannaccone, Maurizio Bertaina, Attilio Leone, Irene Borzillo, Emanuele Ravetti, Andrea Solano, Ilaria Pagliassotto, Marco Nebiolo, Francesco Bruno, Federico Giacobbe, Saverio Muscoli, Silvia Monticone, Maria Felice Brizzi, Giuseppe Biondi Zoccai…
    Citation: Cardiovascular Diabetology 2023 22:324
    Content type: Research Published on:

  26. An obesity paradox has been described in relation to adverse clinical outcomes (e.g., mortality) with lower body mass index (BMI).

    Authors: Tadeusz Osadnik, Dariusz Nowak, Kamila Osadnik, Marek Gierlotka, Adam Windak, Tomasz Tomasik, Mirosław Mastej, Beata Łabuz-Roszak, Kacper Jóźwiak, Gregory Y. H. Lip, Dimitri P. Mikhailidis, Peter P. Toth, Naveed Sattar, Marcin Goławski, Jacek Jóźwiak and Maciej Banach
    Citation: Cardiovascular Diabetology 2023 22:323
    Content type: Research Published on:

  27. The triglyceride-glucose (TyG) index has been proposed as a reliable surrogate marker of insulin resistance and an independent predictor of major adverse cardiovascular events (MACEs). Several recent studies h...

    Authors: Shiyi Tao, Lintong Yu, Jun Li, Zicong Xie, Li Huang, Deshuang Yang, Yuqing Tan, Wenjie Zhang, Xuanchun Huang and Tiantian Xue
    Citation: Cardiovascular Diabetology 2023 22:322
    Content type: Research Published on:

  28. This study aimed to investigate the association between the triglyceride–glucose (TyG) index and left ventricular global longitudinal strain (GLS) in patients with coronary heart disease and to examine the rol...

    Authors: Lin Na, Wenjing Cui, Xinqi Li, Jing Chang and Xin Xue
    Citation: Cardiovascular Diabetology 2023 22:321
    Content type: Research Published on:

  29. The Triglyceride-glucose (TyG) index, a novel indicator of insulin resistance, has been associated with mortality from coronary artery diseases, ischemic stroke, and heart failure. In recent years, much emphas...

    Authors: Jiaqi Chen, Kangxiang Wu, Yiying Lin, Mingyuan Huang and Shanghe Xie
    Citation: Cardiovascular Diabetology 2023 22:320
    Content type: Research Published on:

  30. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which have proven cardiovascular benefits, are recommended in people with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD). Howeve...

    Authors: Xi Tan, Yuanjie Liang, Jigar R. Rajpura, Larisa Yedigarova, Josh Noone, Lin Xie, Silvio Inzucchi and Adam de Havenon
    Citation: Cardiovascular Diabetology 2023 22:319
    Content type: Research Published on:

  31. Diabetes mellitus (DM), heart failure (HF) and metabolic dysfunction associated steatotic liver disease (MASLD) are overlapping diseases of increasing prevalence. Because there are still high numbers of patien...

    Authors: Katarzyna Nabrdalik, Hanna Kwiendacz, Krzysztof Irlik, Mirela Hendel, Karolina Drożdż, Agata M. Wijata, Jakub Nalepa, Oliwia Janota, Wiktoria Wójcik, Janusz Gumprecht and Gregory Y. H. Lip
    Citation: Cardiovascular Diabetology 2023 22:318
    Content type: Research Published on:

  32. Diabetes mellitus (DM) is the most common metabolic disease worldwide and a major risk factor for adverse cardiovascular events, while the additive effects of DM on left ventricular (LV) deformation in the res...

    Authors: Yue Gao, Yi-Ning Jiang, Rui Shi, Ying-Kun Guo, Hua-Yan Xu, Chen-Yan Min, Zhi-Gang Yang and Yuan Li
    Citation: Cardiovascular Diabetology 2023 22:317
    Content type: Research Published on:

  33. Heart failure (HF), chronic kidney disease (CKD), and type 2 diabetes mellitus (T2DM) are common and interrelated conditions, each with a significant burden of disease. HF and kidney disease progress through p...

    Authors: Robert J. Mentz, Stephen A. Brunton and Janani Rangaswami
    Citation: Cardiovascular Diabetology 2023 22:316
    Content type: Research Published on:

  34. The association of glycemic variability with severe consciousness disturbance and in-hospital all-cause mortality in critically ill patients with cerebrovascular disease (CVD) remains unclear, This study aimed...

    Authors: Weimin Cai, Yaling Li, Kun Guo, Xiao Wu, Chao Chen and Xinran Lin
    Citation: Cardiovascular Diabetology 2023 22:315
    Content type: Research Published on:

  35. Diabetes microangiopathy, a hallmark complication of diabetes, is characterised by structural and functional abnormalities within the intricate network of microvessels beyond well-known and documented target o...

    Authors: Dídac Mauricio, Mònica Gratacòs and Josep Franch-Nadal
    Citation: Cardiovascular Diabetology 2023 22:314
    Content type: Review Published on:

  36. Atherogenic index of plasma (AIP) has been demonstrated as a surrogate marker for ischemic stroke, but there is limited evidence for the effect of long-term elevation of AIP on ischemic stroke. Therefore, we a...

    Authors: Huancong Zheng, Kuangyi Wu, Weiqiang Wu, Guanzhi Chen, Zekai Chen, Zefeng Cai, Zhiwei Cai, Yulong Lan, Shouling Wu and Youren Chen
    Citation: Cardiovascular Diabetology 2023 22:313
    Content type: Research Published on:

  37. Metabolic cardiomyopathy (MCM), characterized by intramyocardial lipid accumulation, drives the progression to heart failure with preserved ejection fraction (HFpEF). Although evidence suggests that the mammal...

    Authors: Sarah Costantino, Alessandro Mengozzi, Srividya Velagapudi, Shafeeq Ahmed Mohammed, Era Gorica, Alexander Akhmedov, Alessia Mongelli, Nicola Riccardo Pugliese, Stefano Masi, Agostino Virdis, Andreas Hülsmeier, Christian Matthias Matter, Thorsten Hornemann, Giovanni Melina, Frank Ruschitzka, Thomas Felix Luscher…
    Citation: Cardiovascular Diabetology 2023 22:312
    Content type: Research Published on:

  38. Prior research has established the correlation between insulin resistance (IR) and hypertension. While the association between triglyceride-glucose (TyG) index, a reliable surrogate marker of IR, and uncontrol...

    Authors: Liao Tan, Yubo Liu, Jie Liu, Guogang Zhang, Zhaoya Liu and Ruizheng Shi
    Citation: Cardiovascular Diabetology 2023 22:311
    Content type: Research Published on:

  39. There is growing evidence that ceramides play a significant role in the onset and progression of non-alcoholic fatty liver disease (NAFLD), a highly prevalent condition in patients with type 2 diabetes associa...

    Authors: Damien Denimal, Sarah Béland-Bonenfant, Jean-Paul Pais-de-Barros, Alexia Rouland, Benjamin Bouillet, Laurence Duvillard, Bruno Vergès and Jean-Michel Petit
    Citation: Cardiovascular Diabetology 2023 22:310
    Content type: Research Published on:

  40. The triglyceride glucose-body mass (TyG-BMI) index is acknowledged as both a reliable indicator of the risk of cardiovascular disease and an accurate surrogate biomarker for evaluating insulin resistance (IR)....

    Authors: Jiahao Dou, Chen Guo, Yawen Wang, Zihe Peng, Ruiyun Wu, Qiangqiang Li, Hong Zhao, Shoufang Song, Xuelu Sun and Jin Wei
    Citation: Cardiovascular Diabetology 2023 22:309
    Content type: Research Published on:

  41. Previous studies have investigated the association between the ratio of triglycerides (TG) to high-density lipoprotein cholesterol (HDL-C) and the incidence of diabetes in adults and discovered that a high TG/...

    Authors: Hiroki Yuge, Hiroshi Okada, Masahide Hamaguchi, Kazushiro Kurogi, Hiroaki Murata, Masato Ito and Michiaki Fukui
    Citation: Cardiovascular Diabetology 2023 22:308
    Content type: Research Published on:

  42. This study aimed to explore the association between the triglyceride-glucose (TyG) index and the risk of in-hospital mortality in critically ill patients with sepsis.

    Authors: Rui Zheng, Songzan Qian, Yiyi Shi, Chen Lou, Honglei Xu and Jingye Pan
    Citation: Cardiovascular Diabetology 2023 22:307
    Content type: Research Published on:

  43. Gut microbiota imbalances have been suggested as a contributing factor to atrial fibrillation (AF), but the causal relationship is not fully understood.

    Authors: Huajie Dai, Tianzhichao Hou, Qi Wang, Yanan Hou, Zheng Zhu, Yijie Zhu, Zhiyun Zhao, Mian Li, Hong Lin, Shuangyuan Wang, Ruizhi Zheng, Yu Xu, Jieli Lu, Tiange Wang, Guang Ning, Weiqing Wang…
    Citation: Cardiovascular Diabetology 2023 22:306
    Content type: Research Published on:

  44. The triglyceride-glucose (TyG) index has been proposed as a potential predictor of adverse prognosis of coronary heart disease (CHD). However, its prognostic value in patients with CHD and hypertension remains...

    Authors: Shiyi Tao, Lintong Yu, Jun Li, Li Huang, Xuanchun Huang, Wenjie Zhang, Zicong Xie, Yuqing Tan and Deshuang Yang
    Citation: Cardiovascular Diabetology 2023 22:305
    Content type: Research Published on:

  45. Triglyceride-glucose index (TyG) has been widely used to predict cardiovascular outcomes. However, it remains unclear whether TyG holds prognostic significance for patients with coronary chronic total occlusio...

    Authors: Yu Yang, Mengqing Ma, Jian Zhang, Shiyu Jin, Dingxin Zhang and Xianhe Lin
    Citation: Cardiovascular Diabetology 2023 22:304
    Content type: Research Published on:

  46. Diabetic cardiomyopathy (DCM) is a major complication of diabetes and a risk factor for cardiovascular disease. Endothelial dysfunction is central to DCM, and endothelial-to-mesenchymal transition (EndMT) is a...

    Authors: Eric Wang, Shali Chen, Honglin Wang, Tori Chen and Subrata Chakrabarti
    Citation: Cardiovascular Diabetology 2023 22:303
    Content type: Research Published on:

  47. Recent type 2 diabetes guidance from the UK’s National Institute for Health and Care Excellence (NICE) proposes offering SGLT2-inhibitor therapy to people with established atherosclerotic cardiovascular diseas...

    Authors: Katherine G. Young, Rhian Hopkins, Beverley M. Shields, Nicholas J. Thomas, Andrew P. McGovern and John M. Dennis
    Citation: Cardiovascular Diabetology 2023 22:302
    Content type: Comment Published on:

  48. Sclerostin is an inhibitor of the Wnt/b-catenin pathway, which regulates bone formation, and can be expressed in vascular smooth muscle cells (VSMCs). Type 2 diabetes (T2D) is associated with an increased risk...

    Authors: Sheila González-Salvatierra, Cristina García-Fontana, Jesus Lacal, Francisco Andújar-Vera, Luis Martínez-Heredia, Raquel Sanabria-de la Torre, María Ferrer-Millán, Enrique Moratalla-Aranda, Manuel Muñoz-Torres and Beatriz García-Fontana
    Citation: Cardiovascular Diabetology 2023 22:301
    Content type: Research Published on:

  49. There is uncertainty regarding the role of obesity in type 1 diabetes development. The aim of this systematic review and meta-analysis was to collect and synthesize evidence regarding BMI and the risk of devel...

    Authors: Maya Nitecki, Hertzel C. Gerstein, Yulia Balmakov, Eyal Tsur, Vladislav Babushkin, Tomer Michaeli, Arnon Afek, Orit Pinhas-Hamiel, Tali Cukierman-Yaffe and Gilad Twig
    Citation: Cardiovascular Diabetology 2023 22:300
    Content type: Research Published on:

  50. Circulating N-terminal pro B-type natriuretic peptide (NT-proBNP) is a marker for heart failure in patients with coronary heart disease (CHD) and associated with glycemic abnormalities. Studies on the associat...

    Authors: Tong Yang, Hongmei Zheng, Guangwei Pan, Ruiying Guo, Fengmin Liu, Shengyuan Liu, Shuang Tao, Lin Li, Rongrong Yang and Chunquan Yu
    Citation: Cardiovascular Diabetology 2023 22:299
    Content type: Research Published on:
journal logo

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Submit manuscript

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    56 days submission to accept (Median)

    2023 Usage 
    2,523,778 downloads
    3,115 Altmetric mentions 

Cardiovascular Diabetology

ISSN: 1475-2840